BridgeMD
New treatment option for Oncology
Official title Improving Personalized Treatment in Oncology: Effects of Integrated Oncological Decision-making
ClinicalTrials.gov ID: NCT07046884
What this study is testing
- What it's testing
- The research aims to evaluate an Integrated Oncological Decision-making Model (IODM) to tailor oncological treatment plans to individual patients. The primary objective is to assess the impact of the IODM on personalized decision-making and patient outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient's age = 18+
- Patient is included in participating oncological care path
- Patient does not yet have a treatment plan
- Patient, partner, or caregiver who reads and speaks Dutch sufficiently to understand the research material and to complete the questionnaires
- Patient must be able to participate in the decision-making process
You likely can't join if
- Patient, partner, or caregiver cannot give informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Groningen, Netherlands
- Leiden, Netherlands
- Maastricht, Netherlands
- Sittard, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Groningen, Netherlands; Leiden, Netherlands; Maastricht, Netherlands; Sittard, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.